Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study

Lupus. 2018 Nov;27(13):2020-2028. doi: 10.1177/0961203318801526. Epub 2018 Sep 23.

Abstract

Background: Juvenile-onset systemic lupus erythematosus (JSLE) patients may develop lupus nephritis (LN) during their initial presentation, or later in their disease. This study aimed to assess whether clinical/demographic factors characterize patients with LN within the United Kingdom JSLE Cohort Study, and whether such factors predict subsequent LN development.

Methods: Univariate logistic regression modelling compared clinical/demographic factors in patients with and without LN at baseline. For those who subsequently developed LN, Cox proportional-hazard modelling was used to test the association between such factors and time to LN development. Covariates with p < 0.2 univariately were included within a multiple-regression model.

Results: A total of 121/331 (37%) patients presented with active LN at baseline, with first American College of Rheumatology (ACR) score ( p < 2.0 × 10-16), severe hypertension ( p = 0.0006), proteinuria ( p < 2.0 × 10-16), creatinine ( p = 1.0 × 10-16), erythrocyte sedimentation rate ( p = 1.0 × 10-16), neutrophils ( p < 2.0 × 10-16), complement 3 (C3) ( p = 4.0 × 10-16) and ethnicity ( p = 3.0 × 10-13) differing between those with and without LN. Of the 210 individuals without active LN at baseline, 13 patients had a single visit and were excluded from further analysis. Thirty-four of 197 (17%) developed LN after a median of 2.04 years (interquartile range, 0.8-3.7), with higher ACR scores ( p = 0.014 , hazard ratio (HR) = 1.45, 95% confidence interval (CI) = 1.08-1.95) and lower C3 levels ( p = 0.0082 , HR = 0.27, 95% CI = 0.10-0.68) demonstrated as predictors of subsequent LN.

Conclusions: Clinical and demographic factors can help to characterize patients at increased risk of LN.

Keywords: JSLE; Juvenile-onset systemic lupus erythematosus; UK JSLE Cohort Study; active LN; lupus nephritis.

MeSH terms

  • Adolescent
  • Age of Onset
  • Blood Sedimentation
  • Child
  • Cohort Studies
  • Complement C3 / metabolism
  • Creatinine / blood
  • Female
  • Humans
  • Logistic Models
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / physiopathology*
  • Lupus Nephritis / diagnosis*
  • Lupus Nephritis / epidemiology*
  • Male
  • Multivariate Analysis
  • Neutrophils / cytology
  • Proportional Hazards Models
  • Proteinuria / complications
  • Severity of Illness Index
  • United Kingdom / epidemiology

Substances

  • Complement C3
  • Creatinine